I'm frequently disheartened by the lack of interest the scientific field has in M.E.. Sometimes though there is a glimmer of hope. There is progress. It is slow, and it is not well publicised, but it is happening. I was very excited at the Rituximab study a few weeks ago. Now there is this!
A bloody test that will potentially identify those who have M.E., and also possibly identify those who will respond to treatment with Ampligen.
"Four genes were identified by Multivariate Regression that separated CFS patients from the normal control group.
"Chronix and Hemispherx are currently planning to [...] identify how different persons with CFS can respond to Hemispherx’s experimental drug Ampligen®.
"Ampligen® is an experimental RNA nucleic acid being developed for globally important debilitating diseases and disorders of the immune system."
No comments:
Post a Comment